Skip to content

Jordan Diabetes Microclinic Project

Pilot and Expansion Project for the Jordan Diabetes Microclinic Project

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01596244
Enrollment
2400
Registered
2012-05-10
Start date
2008-04-30
Completion date
2012-08-31
Last updated
2012-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type II

Keywords

Diabetes Mellitus, Type II, Disease management, Chronic disease, Prevention and control, Education

Brief summary

The purpose of the study is to provide participants in economically depressed areas of Jordan essential knowledge, practical skills, and intimate support groups-called microclinics-for managing their diabetes. Microclinics consist of 2-8 individuals from pre-existing social networks (friends, relatives, coworkers, neighbors, etc) that voluntarily participate in ongoing education and medical monitoring from local health care professionals, learning and practicing diabetes management strategies, sharing much-needed medical supplies, and exchanging social support in the form of regular micro-clinic meetings.

Detailed description

The Global Microclinic Project seeks to empower people to prevent and manage diseases in economically depressed areas Jordan. The project seeks to more broadly link health education opportunities in the form of lectures and seminars with practical experience through workshops and hands-on learning, ultimately resulting in the creation of microclinics. Microclinics are intimate support groups of diabetic patients (2-8 per clinic) who meet in their homes and businesses in order to share the costs of maintaining medical monitoring equipment and supplies, come together to support one another in the management of diabetes, collectively utilize vital treatment options, and receive personalized screening, education and management tools from medical professionals. The microclinics concept is ideal for the management of chronic disorders such as diabetes, a disease which requires ongoing education about diet and exercise and regular monitoring of health indices such as blood glucose levels and weight change. Indeed, the microclinics model has been established successfully in the West Bank specifically to combat diabetes. The goal here is to extend the model to Jordan and to establish microclinics in a collaborative effort with the Royal Health Awareness Society (RHAS) and the Jordanian Ministry of Health (MoH).

Interventions

BEHAVIORALMicroclinic

Microclinics consist of 2-8 individuals from pre-existing social networks (friends, relatives, coworkers, neighbors, etc) that voluntarily participate in ongoing education and medical monitoring from local health care professionals, learning and practicing diabetes management strategies, sharing much-needed medical supplies, and exchanging social support in the form of regular microclinic meetings.

Sponsors

Ministry of Health Jordan
CollaboratorOTHER_GOV
Royal Health Awareness Society (RHAS), Jordan
CollaboratorUNKNOWN
Microclinic International
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Over 18 years old * Mentally competent * Have diabetes or pre-diabetes or brought a family member who was diabetic/pre-diabetic (Diabetes: Fasting blood glucose higher than 125 mg/dl; Pre-diabetes: Fasting blood glucose between 100 and 124 mg/dl.)

Exclusion criteria

* They do not meet the above criteria * They are pregnant * They have significant medical complications that prevent them from making changes to diet or level of physical activity.

Design outcomes

Primary

MeasureTime frameDescription
Weight (kg)Baseline, 4 months (intervention), and 12 months (post-intervention)Change in weight overtime

Secondary

MeasureTime frameDescription
Fasting Blood Glucose (mg/dl)Baseline, 4 months, 12 monthsChange in fasting blood glucose overtime
Hemoglobin A1c (%, HBA1c)Baseline, 4 months, 12 monthsChange in HBA1c overtime
Body Mass Index (kg/m2)Baseline, 4 months, 12 monthsChange in body mass index overtime

Countries

Jordan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026